Puberty Blockers

Puberty blocker use is an area that we get a lot of questions about, so it is important that we share well-balanced, evidence-based information with our wider networks.

The following article was published in the International Journal of Transgender Health, written by a group of leading clinicians and researchers from WPATH. It summarises the Bell Tavistock situation, the current and evolving evidence around puberty blockers, and appreciating some of the challenges when evidence is still emerging.

You can also read this paper on the publisher's website